Allworth Financial LP

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 1555170 FOLSOM, CA

Position in HRTX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$6,166

-$1,452 QoQ

Shares Held

14,341

+50.6% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#115

of 161 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Allworth Financial LP holds $18,605,644 across 285 Biotechnology names. HRTX ranks #151 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	37,664	$2,947,961
2	VRTX	Vertex Pharmaceuticals Inc / Ma	4,487	$2,228,827
3	MDGL	Madrigal Pharmaceuticals, Inc.	3,562	$1,912,615
4	REGN	Regeneron Pharmaceuticals, Inc.	2,530	$1,577,556
5	INCY	Incyte Corp	5,182	$587,431
6	EXEL	Exelixis, Inc.	10,562	$574,678
7	CRSP	CRISPR Therapeutics AG	10,089	$550,254
8	RVMD	Revolution Medicines, Inc.	2,240	$419,507

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,166	14,341	+50.6%	Shares	Sole	2026-08-11
2026-03-31	$7,618	9,523	+2.1%	Shares	Sole	2026-05-15
2025-12-31	$12,127	9,329	+500.3%	Shares	Sole	2026-02-05
2025-09-30	$1,958	1,554	+4340.0%	Shares	Sole	2025-12-02
2025-06-30	$72	35	-88.4%	Shares	Sole	2025-08-07
2024-09-30	$598	301	0.0%	Shares	Sole	2024-10-23
2024-06-30	$1,053	301	0.0%	Shares	Sole	2024-07-24
2024-03-31	$833	301	0.0%	Shares	Sole	2024-04-25
2023-12-31	$511	301	+100.7%	Shares	Sole	2024-01-24
2021-09-30	$1,603	150	0.0%	Shares	Sole	2021-11-02
2021-06-30	$2,328	150	0.0%	Shares	Sole	2021-08-02
2021-03-31	$2,431	150	0.0%	Shares	Sole	2021-04-29
2020-12-31	$3,175	150	—	Shares	Sole	2021-01-26
No filing history on record for this holder in this stock.